Galapagos NV
25.76
21-February-25 08:38:02
15 minutes delayed
Stocks
+0.34
+1.34%
Today's range
25.60 - 25.86
ISIN
BE0003818359
Source
Cboe
-
Galapagos 2021 results set stage for future growth
24 Feb 2022 15:01:00 By Nasdaq GlobeNewswire
-
Galapagos receives transparency notification from EcoR1 Capital
03 Feb 2022 15:01:00 By Nasdaq GlobeNewswire
-
02 Feb 2022 15:01:00 By Nasdaq GlobeNewswire
-
Galapagos creates new subscription right plan
26 Jan 2022 15:40:00 By Nasdaq GlobeNewswire
-
Galapagos appoints Paul Stoffels as Chief Executive Officer
26 Jan 2022 15:01:00 By Nasdaq GlobeNewswire
-
18 Jan 2022 15:01:00 By Nasdaq GlobeNewswire
-
Galapagos creates new subscription right plan
13 Jan 2022 15:01:00 By Nasdaq GlobeNewswire
-
Galapagos to present at 40th Annual J.P. Morgan Healthcare Conference
06 Jan 2022 08:30:00 By Nasdaq GlobeNewswire
-
Galapagos increases share capital through subscription right exercises
03 Dec 2021 15:01:00 By Nasdaq GlobeNewswire
-
22 Nov 2021 15:01:00 By Nasdaq GlobeNewswire
-
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
15 Nov 2021 09:45:07 By Nasdaq GlobeNewswire
-
Galapagos reports commercial and operational progress at Q3 financial results
04 Nov 2021 16:01:00 By Nasdaq GlobeNewswire
-
04 Oct 2021 15:01:00 By Nasdaq GlobeNewswire
-
04 Oct 2021 00:01:00 By Nasdaq GlobeNewswire
-
Galapagos increases share capital through subscription right exercises
20 Sep 2021 15:01:00 By Nasdaq GlobeNewswire
-
17 Sep 2021 06:15:00 By Nasdaq GlobeNewswire
-
Galapagos announces planned retirement of CEO
30 Aug 2021 15:01:00 By Nasdaq GlobeNewswire
-
Galapagos reports H1 financial results with refocused pipeline and operational progress
05 Aug 2021 15:01:00 By Nasdaq GlobeNewswire
-
Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation
14 Jul 2021 15:01:00 By Nasdaq GlobeNewswire
-
14 Jul 2021 15:01:00 By Nasdaq GlobeNewswire